Tumor Promoting Aspects of Senescence in Cancer Progression

被引:1
|
作者
Yang, Qing [1 ]
Xie, Yingqiu [1 ]
Miao, Lixia [2 ]
机构
[1] Nazarbayev Univ, Sch Sci & Technol, Dept Biol, 53 Kabanbay Batyr Ave, Astana 010000, Kazakhstan
[2] Wuhan Univ, Coll Basic Med, Wuhan, Peoples R China
关键词
Senescence; cancer; EPITHELIAL-MESENCHYMAL TRANSITION; SUPPRESSES PROSTATE-CANCER; CELLULAR SENESCENCE; CELLS; METASTASIS; PATHWAYS; PTEN; TUMORIGENESIS; GROWTH; ARF;
D O I
10.1080/07357907.2016.1227443
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancers induced by gene mutation, deletion, and genome instability might be related to aging. With similar pathways of aging but distinct functions, senescence at the cellular level is an irreversible arrest of cell cycle. Senescence has long been believed as a barrier to restrict tumor expansion. However, more and more evidence has been shown that senescence inducers regulate epithelial-mesenchymal transition, stem cell self-renewal, inflammatory response, crosstalk with the oncogenic bypass signaling, and conversion of oncogene to tumor suppressor. Here we will discuss the most recent findings of the oncogenic aspects of senescence which crosstalk with multiple pathways in cancer progression.
引用
收藏
页码:452 / 458
页数:7
相关论文
共 50 条
  • [21] Senescence in cancer and myeloid cells control prostate cancer progression
    Alimonti, Andrea
    CANCER RESEARCH, 2023, 83 (11)
  • [22] The dual role of cellular senescence in human tumor progression and therapy
    Ma, Liang
    Yu, Jie
    Fu, Yidian
    He, Xiaoyu
    Ge, Shengfang
    Jia, Renbing
    Zhuang, Ai
    Yang, Zhi
    Fan, Xianqun
    MEDCOMM, 2024, 5 (09):
  • [23] Senescence Connects Autophagy Deficiency to Inflammation and Tumor Progression in the Liver
    Huda, Nazmul
    Khambu, Bilon
    Liu, Gang
    Nakatsumi, Hirokazu
    Yan, Shengmin
    Chen, Xiaoyun
    Ma, Michelle
    Dong, Zheng
    Nakayama, Keiichi I.
    Yin, Xiao-Ming
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2022, 14 (02): : 333 - 355
  • [24] Short telomeres limit tumor progression in vivo by inducing senescence
    Feldser, David M.
    Greider, Carol W.
    CANCER CELL, 2007, 11 (05) : 461 - 469
  • [25] Drivers of centrosome abnormalities: Senescence progression and tumor immune escape
    Jiang, Tao
    Jin, Hua
    Ji, Xintong
    Zheng, Xi
    Xu, Cheng-Xiong
    Zhang, Peng-Jun
    SEMINARS IN CANCER BIOLOGY, 2025, 110 : 56 - 64
  • [26] Snail Bypasses Senescence and Accelerates Tumor Progression in a Kras-driven Mouse Model of Pancreatic Cancer
    Paul, M. C.
    Walter, B. M.
    Seidler, B.
    Schnieke, A.
    Schmid, R. M.
    Schneider, G.
    Saur, D.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S168 - S169
  • [27] HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer
    Cheng, Yifei
    Li, Lu
    Wei, Xiyi
    Xu, Fan
    Huang, Xiaochen
    Qi, Feng
    Zhang, Yanyan
    Li, Xiao
    CANCER SCIENCE, 2023, 114 (05) : 1830 - 1845
  • [28] MAD2L2, a key regulator in ovarian cancer and promoting tumor progression
    Kejun Xu
    Xiaojiao Zheng
    Hongyan Shi
    Jilan Ou
    Huiqing Ding
    Scientific Reports, 14
  • [29] The promoting effect of fibroblasts on growth and progression of tumor cells
    Kolodovsky, P
    Haas, I
    FASEB JOURNAL, 1996, 10 (06): : 850 - 850
  • [30] AOC1 Contributes to Tumor Progression by Promoting the AKT and EMT Pathways in Gastric Cancer
    Xu, Fen
    Xu, Yun
    Xiong, Jian-Hui
    Zhang, Jing-Hui
    Wu, Jian
    Luo, Jie
    Xiong, Jian-Ping
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 1789 - 1798